srobinson on DSK4SPTVN1PROD with NOTICES

Federal Register / Vol. 77, No. 32 / Thursday, February 16, 2012 / Notices 9251 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–3645 Filed 2–15–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Linde Ceramics 

Plant in Tonawanda, New York, as an 

addition to the Special Exposure Cohort 

(SEC) under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. On February 2, 

2012, the Secretary of HHS designated 

the following class of employees as an 

addition to the SEC: 

All Atomic Weapons Employees who 

worked in any area at the Linde Ceramics 

Plant in Tonawanda, New York, from 

November 1, 1947, through December 31, 

1953, for a number of work days aggregating 

at least 250 work days, occurring either 

solely under this employment or in 

combination with work days within the 

parameters established for one or more other 

classes of employees included in the SEC. 

This designation will become effective 

on March 3, 2012, unless Congress 

provides otherwise prior to the effective 

date. After this effective date, HHS will 

publish a notice in the Federal Register 

reporting the addition of this class to the 

SEC or the result of any provision by 

Congress regarding the decision by HHS 

to add the class to the SEC. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 4676 Columbia Parkway, MS 

C–46, Cincinnati, OH 45226, Telephone 

1–877–222–7570. Information requests 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–3646 Filed 2–15–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Determination Concerning a Petition 

To Add a Class of Employees to the 

Special Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

determination concerning a petition to 

add a class of employees from the 

Hooker Electrochemical Company in 

Niagara Falls, New York, to the Special 

Exposure Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000 

(EEOICPA), 42 U.S.C. 7384q. On 

February 2, 2012, the Secretary of HHS 

determined that the following class of 

employees does not meet the statutory 

criteria for addition to the SEC as 

authorized under EEOICPA: 

All employees who worked in any location 

at the Hooker Electrochemical Corporation 

during the operational period from January 1, 

1943, through December 31, 1948, and during 

the residual period from January 1, 1949, to 

December 31, 1976. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health (NIOSH), 4676 

Columbia Parkway, MS C–46, 

Cincinnati, OH 45226, Telephone 

1–877–222–7570. Information requests 

can also be submitted by email to 

DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–3644 Filed 2–15–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Solicitation of Nominations for 

Membership on the Secretary’s 

Advisory Committee on Human 

Research Protections 

AGENCY: Department of Health and 

Human Services, Office of the Secretary, 

Office of the Assistant Secretary for 

Health, Office for Human Research 

Protections. 

ACTION: Notice. 

Authority: 42 U.S.C. 217a, Section 222 of 


the Public Health Service Act, as amended. 


The Committee is governed by the provisions 


of Public Law 92–463, as amended (5 U.S.C. 

Appendix 2), which sets forth standards for 

the formation and use of advisory 

committees. 

SUMMARY: The Office for Human 

Research Protections (OHRP), a program 

office in the Office of the Assistant 

Secretary for Health, Department of 

Health and Human Services (HHS), 

previously published a notice (76 FR 

243, 19 Dec 2011, pp. 78660–78661) 

seeking nominations of qualified 

candidates to be considered for 

appointment as members of the 

Secretary’s Advisory Committee on 

Human Research Protections (SACHRP). 

OHRP would like to announce a four 

week extension of the SACHRP 

nomination period. As a result of this 

extension, the nomination period will 

now end at the close of business on 

March 16, 2012. 

DATES: Nominations for membership on 

the Committee must be received no later 

than March 16, 2012. 

ADDRESSES: Nominations should be 

mailed or delivered to Dr. Jerry 

Menikoff, Director, Office for Human 

Research Protections, Department of 

Health and Human Services, 1101 

Wootton Parkway, Suite 200, Rockville, 

MD 20852. Nominations will not be 

accepted by email or by facsimile. 

FOR FURTHER INFORMATION CONTACT: Julia 

Gorey, Executive Director, SACHRP, 

Office for Human Research Protections, 

1101 Wootton Parkway, Suite 200, 

Rockville, MD 20852, telephone: 240– 

453–8141. A copy of the Committee 

charter and list of the current members 

can be obtained by contacting Ms. 

Gorey, accessing the SACHRP Web site 

at www.hhs.gov/ohrp/sachrp, or 

requesting them via email at 

sachrp@osophs.dhhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Committee provides advice on matters 

pertaining to the continuance and 

improvement of functions within the 

authority of HHS directed toward 

protections for human subjects in 

research. Specifically, the Committee 

provides advice relating to the 

responsible conduct of research 

involving human subjects with 

particular emphasis on special 

populations such as neonates and 

children, prisoners, the decisionally 

impaired, pregnant women, embryos 

and fetuses; individuals and 

populations in international studies, 

investigator conflicts of interest and 

research involving individually 

identifiable samples, data or 

information. 

In addition, the Committee is 

responsible for reviewing selected 

ongoing work and planned activities of